Community-powered recruitment · Global

Reach patients through the organizations they already trust.

Paid ads only find the patients already searching. Bridge reaches the rest — through the advocacy groups, community clinics and provider networks that already serve your study population — and turns them into a compliant referral engine for your trial.

512,765 organizations 10 countries 85,226 care providers 54 conditions
The Bridge network footprint and client portal
The network your study plugs into

A standing global network, ready on day one.

A living map of relationships with the organizations that reach real patients — mapped, verified and remembered across studies, so your next trial starts warm.

512,765
Organizations mapped
10
Countries
85,226
Care providers & clinics
54
Conditions · 16 areas
20–68%
Partner reply rates

Live registry counts as of Sep 2026 · 442,741 confirmed trial-relevant · 80,177 mapped to a specific condition. Operators see the always-live footprint in the dashboard.

See it work

Two short tours of the real product.

The global network your study plugs into, and the client portal where you watch it work — both live, both yours.

The network footprint

The global map, reach by condition, the communities served, and country-level census depth.

The client portal

Your programs at a glance, outreach health scored and explained, and every named partner behind each study.

Page through a full strategy Bridge produced.

A real (demo) plan end to end: funnel, reach, partner channels, catchment map and the six-month program.

Open the full strategy →
Why it matters

Research should reach everyone, not just the easy to find.

Clinical trials have a reach problem. The people who could benefit most — families facing a rare diagnosis, patients in rural towns, communities research has long overlooked — are too often the last to hear that a study even exists.

Bridge changes who gets asked. Instead of cold ads, we reach people through the advocacy groups, clinics and community leaders they already know. When an invitation comes from someone you trust, it lands differently, and doors that used to stay closed start to open.

It is also how a Diversity Action Plan gets carried out, not just filed.

🤝

Built on trust

We meet patients where they already are, through organizations that earned their community's trust over years, not overnight.

🌍

Access for the overlooked

Rural, underserved and historically excluded communities get a real seat at the table, not an afterthought once enrollment stalls.

💙

People, not leads

Every referral is someone's mother, son or neighbor — getting a chance they might never have heard about otherwise.

What Bridge does

An end-to-end community-outreach engine.

Built to reach patients through the people and organizations they already trust — from finding the right partners to a warm referral in your portal.

🎯

Finds the right partners

We pinpoint the advocacy groups, clinics, provider networks and community organizations that already reach your study population — matched to your indication and catchment, and carefully curated so outreach is targeted, never spam.

📣

Meets communities on every channel

We engage partners the way they actually connect: email, social and professional networks — with respectful, fully compliant, opt-out-friendly messaging that never over-contacts one organization.

💬

Turns interest into referrals

Every reply gets a real response. Interested partners are guided to refer patients to the right study, and each relationship is kept warm across the whole organization.

🧭

A welcoming front door for patients

A clean, patient-friendly study finder helps interested people find the right study and next step by condition and location — the trusted entry point for community referrals.

🗂️

Built for multi-site programs

Running one indication across many sites? We engage the community once and connect each interested patient to their best-fit site, with a single rolled-up view across the whole program.

📊

Live visibility for your team

Log in any time to watch engagement, referrals and your community footprint update in real time — progress you can see unfold, not a weekly status deck.

Who it's for

One engine, every kind of study team.

However you run trials, Bridge adds the community-referral channel that paid media can't reach — scoped to how you work.

🧪

Sponsors

Carry out your Diversity Action Plan for real, reaching the communities paid media misses — with a referral trail you can put in front of the FDA.

🏢

CROs

Add a community-referral channel to any protocol you run. Flat-fee, priced to compound down across a portfolio, and something you can name in the bid.

🏥

Site networks & SMOs

Feed every site a warm, pre-qualified referral stream from the advocacy groups and clinics around it — one indication engaged once, routed to the best-fit site.

🎓

Academic & investigator sites

Run real community outreach for an investigator-initiated study without standing up a recruitment team — from a single indication to a whole department.

Global reach

One outreach engine, tuned to each market.

Every market maps to its own networks and rules — US community health centers and FQHCs, UK NHS trusts and disease charities, EU patient organizations, South African community networks — with catchment demographics from official census sources and outreach aligned to each region's research-ethics and privacy standards.

🇺🇸
United States
241,133 orgs
🇮🇹
Italy
145,660 orgs
🇬🇧
United Kingdom
56,093 orgs
🇫🇷
France
30,630 orgs
🇮🇪
Ireland
14,169 orgs
🇧🇪
Belgium
11,697 orgs
🇿🇦
South Africa
11,632 orgs
🇪🇸
Spain
1,315 orgs · expanding
🇳🇱
Netherlands
238 orgs · expanding
🇩🇪
Germany
198 orgs · expanding

Types of partners

Community providers and clinics52%
Advocacy organizations20%
Academic medical centers10%
Researchers and KOLs5%
Specialist clinics4%
Other partners9%

How the network is built

  • ✓Verified organizations. Built from public patient-organization and health registries in every market, confirmed active for your indication.
  • ✓Advocacy and foundation mapping. The disease-specific organizations that families in your indication already turn to.
  • ✓Matched to your study. Filtered to your indication and each site's catchment, then human-reviewed before anyone is contacted.
  • ✓Institutional memory. Every relationship is remembered across studies, so the next trial starts warm.
Representation you can evidence

Real reach into under-represented communities — measured per market.

Each market is measured against its own official census metric, so the number means what the regulator in that region means by it.

🇺🇸United States
61.1%

from under-represented groups · vs 42.6% baseline

40.2M reached 146 areas
Hispanic or Latino26.5%
Black20.4%
Asian8.8%

US Census Bureau · ACS (B03002)

🇬🇧United Kingdom
18.8%

ethnic-minority residents · vs 18.3% baseline

6.1M reached 127 areas

ONS · Census 2021 (TS021)

🇪🇺European Union
15.7%

foreign-born residents · vs 13.4% baseline

46.1M reached 7 countries

Eurostat · 2023

🇿🇦South Africa
92.3%

from historically under-represented groups

57.5M reached 9 provinces

Statistics South Africa · Census 2022

This is what turns a Diversity Action Plan into something you can evidence, not just state.

Conditions and specialties worked across

Inherited metabolic disordersNeurologyAddiction and substance useHearing and deafnessPsychiatry and behavioral healthHematologyRare and genetic conditionsPediatricsNeuromuscular 54 conditions · 16 therapeutic areas
Proof of breadth

The organizations Bridge can reach for your indication.

A real count of the registered patient organizations and health charities Bridge can mobilize across the conditions the model is built for. Every figure is a live directory count, shown here for the two deepest markets.

United States United Kingdom

CNS & psychiatry

Depression, Alzheimer's, Parkinson's, epilepsy, MS, ALS, schizophrenia, Huntington's

US
1,873
UK
444

Oncology

Breast cancer, multiple myeloma

US
1,179
UK
57

Rare & genetic

Sickle cell disease, cystic fibrosis

US
233
UK
35

Autoimmune

Lupus, rheumatoid arthritis

US
207
UK
39
3,492
US organizations across these conditions
575
UK organizations across these conditions
See every indication ›
Breast cancer
823
51
Depression (MDD)
433
192
Multiple myeloma
356
6
Alzheimer's
325
138
Parkinson's
313
27
Multiple sclerosis
253
32
ALS / MND
211
4
Sickle cell disease
190
24
Epilepsy
189
26
Lupus (SLE)
131
8
Huntington's
78
23
Rheumatoid arthritis
76
31
Schizophrenia
71
2
Cystic fibrosis
43
11
How it works

From protocol to a warm referral.

1

Define the study

We build an indication-level partner profile: the org types, specialties and geographies that reach your population.

2

Find and vet partners

We build a targeted, vetted list of the organizations and people who genuinely fit your study. Quality over quantity, no spam lists.

3

Engage and refer

We reach out respectfully across the right channels, respond to every reply, and help interested partners refer patients to the right study.

4

See the results

Track engagement, referrals and the community footprint live in your client portal.

The CliniContact platform

Bridge is one half of how CliniContact fills a study.

CliniContact runs two recruitment engines that share one participant record. Most studies use both: Horizon reaches the patients who are searching, Bridge reaches the ones who are not.

HorizonStartup & digital recruitment

Give Horizon a protocol link or PDF, and about an hour later you have the full recruitment package and a study-specific marketing strategy, screened for IRB and platform compliance. Then we build and run the digital ad campaigns, tuned weekly to cost-per-qualified-candidate.

  • ✓Recruitment package + marketing strategy in about an hour
  • ✓Managed paid-media campaigns; you set the ad spend, no markup
  • ✓Smart Screener and Vision included
See Horizon →
BridgeCommunity & referral pathways

The community-outreach engine on this page. Bridge reaches patients through the advocacy groups, clinics and communities that already serve them, and turns those relationships into a compliant referral pathway — built to evidence a Diversity Action Plan.

  • ✓Partner networks matched to your indication and catchment
  • ✓Reaches underserved communities paid media misses
  • ✓Smart Screener and Vision included
You are here ↑

One participant record across both, so a lead from a Facebook group and a lead from a paid ad land in the same place, screened the same way.

Pricing

Priced per indication, not per study.

One indication covers every study you run in it. Bridge is priced by how hard the community is to reach, and nothing else. No management fee, no markup.

Established communities

$1,200/ indication / month

High-prevalence conditions with broad advocacy and community networks already in place.

DepressionAlzheimer'sParkinson'sEpilepsyBreast cancerRheumatoid arthritis
Most common

Complex reach

$1,500/ indication / month

Specialized communities with fewer, harder-to-find partners, and more field-building to open the pathways.

Multiple sclerosisSickle cell diseaseSchizophreniaLupusMultiple myeloma

Rare & hardest

$1,800/ indication / month

Ultra-low prevalence and tightly concentrated communities, where every partner counts.

ALS / MNDHuntington'sCystic fibrosis
New to Bridge? Run one study on the full Horizon + Bridge engine for $1,200/mo, with $300 toward your first month of ad spend. Start your pilot →

No management fee · No ad-spend markup · No per-seat or setup fees

Minimum term: Horizon 3 months, Bridge 6 months. Community outreach needs the runway to build partner relationships.

Running several indications or a site network? Request a full quote →

FAQ

Common questions.

How is Bridge different from a recruitment vendor?+

Most vendors buy lists or run more ads. Bridge builds real relationships with the organizations a community already trusts, then turns interest into vetted referrals. Nothing is spam, every reply gets a human response, and each relationship is remembered across studies.

Do you contact patients directly?+

No. Bridge engages organizations — advocacy groups, clinics, provider networks. They share the study with the people they serve, and interested patients come to a clean study finder on their own terms. Individual contact details stay with the outreach team, never the client.

Is outreach compliant?+

Yes. Messaging is respectful, opt-out-friendly and never over-contacts one organization, and it is aligned to each market's research-ethics and privacy standards — FDA/IRB and HIPAA in the US, HRA/REC and UK GDPR in the UK, and the equivalents across the EU and South Africa.

How does Bridge help a Diversity Action Plan?+

Bridge reaches under-represented communities through the organizations that already serve them, and every referral leaves a trail. That turns a Diversity Action Plan from something you file into something you can evidence — with real reach into the communities paid media misses.

Can we run Bridge without Horizon?+

Yes. Bridge is a standalone community-outreach engine. Most studies run it alongside Horizon so paid and community leads share one participant record, but you can run either on its own.

What do I see in the client portal?+

Your programs at a glance, a scored outreach-health view per study with a plain-language progress summary, every named partner engaged on your study, and referrals as they come in — updating live, not in a weekly deck.

Bring community reach to your next study.

Log in to your Bridge portal to see live progress, or talk to our team about standing up outreach for a new study.

Prefer email? info@bridge-by-clinicontact.com